eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2006, Volume 2, Issue 3 : 319-325 doi: ijmmas.2006.319.325
Research Article
Cytopathogenicity Modifies Antigenic Expression Profiles in Viral Hepatitis B-Infected Hepatocytes
Published
Sept. 30, 2005
Abstract

A whole spectrum of consequence of viral hepatitis injury implicates directly a modulated antigenic profile expression that further modifies quantitatively the immune response to the infection.  It is in terms of such consequence that cytopathic injury and cytotoxicity as induced by T lymphocytes induce an ongoing injury to hepatocytes. Persistence of injury is itself another parameter of activity in accounting for transformation of the expression profile of infected hepatocytes.  The immune response would be sustained in the presence of persistent viral DNA in serum and tissues and in further allowing for transformation. The infected hepatocyte is indeed an expression consequence of injury that is precipitated by viral infection and driven by changing antigenic profile reactivity of the liver cells.  The cytotoxic T lymphocytes would transcend aspects of targeting or pooling dynamics within the liver but would promote consequences of injury as quantitatively predetermined immunologic response in perinatal or adult studies. Derived consequence of hepatocyte injury ranges from clearance of virus to acute and chronic hepatitis to a persistent state of antigenicity that perhaps may culminate in hepatocellular carcinogenesis.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Community-Based Health Programs and Their Effectiveness: Evaluating Impacts on Population Health Outcomes
13-19
Personalized Healthcare Using Genomic Data: Advancing Precision Medicine Through Genomic Innovation
51-55
Mental Health Awareness and Help-Seeking Behavior: A Comprehensive Study of Knowledge, Attitudes, Barriers, and Interventions
7-12
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.